- MYL has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $1.0 billion.
- MYL is down 2.5% today from today's close.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in MYL with the Ticky from Trade-Ideas. See the FREE profile for MYL NOW at Trade-Ideas More details on MYL: Mylan N.V., through its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals worldwide. MYL has a PE ratio of 31.6. Currently there are 8 analysts that rate Mylan a buy, no analysts rate it a sell, and 2 rate it a hold. The average volume for Mylan has been 8.5 million shares per day over the past 30 days. Mylan has a market cap of $36.2 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.82 and a short float of 6.4% with 1.82 days to cover. Shares are up 31.1% year-to-date as of the close of trading on Monday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.